WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

A CLINICAL STUDY OF ‘TAGARADI KWATHA’ AND ‘TAKRA AMALAKI SHIRODHARA’ IN THE MANAGEMENT OF ‘UCCHA RAKTA CHAPA’ W.S.R TO ESSENTIAL HYPERTENSION

Dr. Preeti Prajapat*, Dr. Suman Bishnoi, Dr. Pramod Kumar Mishra and Dr. Indu Sharma

Abstract

Hypertension (HTN or HT), as known as high blood pressure or arterial hypertension, is a chronic medical condition caused by persistently elevated blood pressure in the arteries. Hypertension is a major risk factor for the progression of cardiovascular and cerebrovascular disease, both of which have a high mortality and morbidity rate. It is mostly responsible for strokes and end-stage renal failure. It's also responsible for the improvement of coronary artery disease. It is asymptomatic yet has dreadful effects on the body. It's called the 'Silent or Hidden Killer' because most of sufferers are asymptomatic and in more than 95% cases of hypertension under lying causes is not found. Such patients are said to have Essential Hypertension. According to the WHO's annual report from 2004, India has a four times higher prevalence in all age groups than other developed countries. Hypertension is a common disorder with a growing incidence. Aims and Objectives: The study has been planned with the following aims & objectives. To study the etiopathogenesis of Uccha Rakta Chapa W.S.R. to essential HTN on the basis of Ayurvedic principles. To study the efficacy & safety of Tagaradi Kwatha & Takra-Amalaki Shirodhara in management of Hypertension. Materials and Methods: Following materials & Methods were adopted for conducting the present research project. (1) Selection of cases The study was conducted on 40 clinically diagnosed & confirmed patients of Hypertension. The selection of patients were made from OPD and IPD of PG Department of Kayachikitsa in DSRRAU hospital, Jodhpur. After the complete examination and investigation all the patients were divided into two groups and randomly described as below. Group A- 20 well diagnosed and confirmed patients of Uccha Rakta Chapa (HTN) were administered with Tagaradi Kwatha 10gm twice a day for 30 days. Group B – 20 well diagnosed and confirmed patients of Uccha Rakta Chapa (HTN) were administered with Tagaradi Kwatha 10gm twice a day for 30 days along with Takra-Amalaki Shirodhara for 10 days. Result - After treatment it can be saying that Good relief / Moderate relief in group A and Satisfactory / Significant relief was found in group B were found in given symptoms. Conclusion- Therefore, it can be concluded that, Both Tagaradi Kwatha and Takra Amalaki Shirodhara have been shown to reduce systolic and diastolic blood pressure as well as relieve the symptoms of essential hypertension and safe and effective in the management of Uccha Rakta Chapa (Essential Hypertension).

Keywords: Uccha Rakta Chapa, Essential hypertension.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More